Drugs News and Research

RSS

Scientists develop new receptor “decoy” drug that potently neutralizes SARS-CoV-2 variants

Scientists at Dana-Farber Cancer Institute have developed a drug that potently neutralizes SARS-CoV-2, the COVID-19 coronavirus, and is equally effective against the Omicron variant and every other tested variant.

7 Dec 2022

Enrollment in Medicare Advantage not associated with higher rate of heart attack survival

Nearly half of Americans with Medicare now get their health insurance coverage through a private company that takes part in the federal government's Medicare Advantage program.

7 Dec 2022

T-DXd leads to longer overall survival in HER2-positive metastatic breast cancer patients than T-DM1

Second-line treatment with trastuzumab deruxtecan (T-DXd) led to significantly longer overall survival compared with trastuzumab emtansine (T-DM1) in patients with HER2-positive metastatic breast cancer, according to updated results from the DESTINY-Breast03 phase III clinical trial presented at the San Antonio Breast Cancer Symposium, held December 6-10, 2022.

7 Dec 2022

HIV transmission from mother to child can be stopped with modern antiviral drugs

Antiviral drugs almost completely reduce the risk of mothers passing on HIV infection to their children, even in a low-income country with a high HIV incidence such as Tanzania, according to a new study in The Lancet HIV by researchers from Karolinska Institutet.

7 Dec 2022

Wearable technology could improve doctors' ability to administer precise medication doses

For some of the powerful drugs used to fight infection and cancer, there's only a small difference between a healing dose and a dose that's large enough to cause dangerous side effects.

7 Dec 2022

Study allows people with type 2 diabetes to choose their own medication

A large-scale new study offers a new approach to treating type 2 diabetes - that puts patients in charge of their own medication. The Trimaster study is the first to allow people with type 2 diabetes to choose their own medication, after trying three different drugs in succession.

7 Dec 2022

Paxlovid has been free so far. Next year, sticker shock awaits.

Nearly 6 million Americans have taken Paxlovid for free, courtesy of the federal government. The Pfizer pill has helped prevent many people infected with covid-19 from being hospitalized or dying, and it may even reduce the risk of developing long covid.

7 Dec 2022

Self-service vending machine filled with harm reduction supplies helps prevent overdoses

More than 107,000 Americans died from drug overdose in 2021, highlighting the need for evidence-based interventions.

6 Dec 2022

Research extends the powerful tool of immunotherapy to autoimmune diseases

The cancer therapy known as CAR-T has revolutionized treatment of some blood cancers since it was introduced in 2017. The therapy uses genetically altered immune cells to home in on cancer cells and destroy them.

6 Dec 2022

Study provide new insights into why cholestasis causes cognitive issues

Patients with cholestatic liver disease such as primary biliary cholangitis (PBC) can experience significant impairment of bile flow and may develop neurological symptoms including fatigue and cognitive decline.

6 Dec 2022

Unique technology uses ultrasound-responsive nanobubbles for treating osteoporosis

University of Central Florida researchers have created unique technology for treating osteoporosis that uses nanobubbles to deliver treatment to targeted areas of a person's body.

6 Dec 2022

Study suggests new anti-KRAS drug as a strong candidate for pancreatic cancer clinical trials

A small molecule inhibitor that attacks the difficult to target, cancer-causing gene mutation KRAS, found in nearly 30 percent of all human tumors, successfully shrunk tumors or stopped cancer growth in preclinical models of pancreatic cancer, researchers from Penn Medicine's Abramson Cancer Center showed, suggesting the drug is a strong candidate for clinical trials.

6 Dec 2022

Drugs News and Research

Scientists develop new receptor “decoy” drug that potently neutralizes SARS-CoV-2 variants

Enrollment in Medicare Advantage not associated with higher rate of heart attack survival

T-DXd leads to longer overall survival in HER2-positive metastatic breast cancer patients than T-DM1

HIV transmission from mother to child can be stopped with modern antiviral drugs

Wearable technology could improve doctors' ability to administer precise medication doses

Study allows people with type 2 diabetes to choose their own medication

Paxlovid has been free so far. Next year, sticker shock awaits.

Self-service vending machine filled with harm reduction supplies helps prevent overdoses

Research extends the powerful tool of immunotherapy to autoimmune diseases

Study provide new insights into why cholestasis causes cognitive issues

Unique technology uses ultrasound-responsive nanobubbles for treating osteoporosis

Study suggests new anti-KRAS drug as a strong candidate for pancreatic cancer clinical trials

The critical role of flow cytometry in CAR+ T-Cell trials

Laos malaria outbreak in 2020–21 likely caused by multidrug-resistant strains of P. falciparum

Researchers discover new mechanism that enables cancer cells to move throughout the body

Trial assesses the impact of two immunomodulators in reducing CV risk among rheumatoid arthritis patients

Study explores practical pathways to motherhood in women with oncogene-driven lung cancer

Discovery offers an avenue for development of novel therapies for Chagas disease

Trial shows acoziborole drug clears body of African sleeping sickness parasites

Researchers develop potent yet low-inflammatory mRNA cancer vaccine vectors

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News